Anthem Biosciences Ltd Share Price – NSE  / BSE

Pharmaceuticals, Small Cap

Anthem Biosciences announced that the 20th Annual General Meeting(AGM) of the company will be held on 22 July 2026.

Anthem Biosciences announced that the Board of Directors of the Company at its meeting held on 19 May 2026, inter alia, have recommended the final dividend of Rs 2 per equity Share (i.e. 100%) , subject to the approval of the shareholders.

Net profit of Anthem Biosciences rose 129.68% to Rs 189.76 crore in the quarter ended March 2026 as against Rs 82.62 crore during the previous quarter ended March 2025. Sales rose 26.44% to Rs 610.94 crore in the quarter ended March 2026 as against Rs 483.20 crore during the previous quarter ended March 2025.

For the full year,net profit rose 31.14% to Rs 591.79 crore in the year ended March 2026 as against Rs 451.26 crore during the previous year ended March 2025. Sales rose 15.17% to Rs 2124.33 crore in the year ended March 2026 as against Rs 1844.55 crore during the previous year ended March 2025.

Powered by Capital Market - Live News

Anthem Biosciences will hold a meeting of the Board of Directors of the Company on 19 May 2026.